First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
More stories
Mitchell
News Release
Keeping Your Remote Teams Engaged in a Changing World
The world is currently facing many uncertainties, including a sweeping surge of work from home requirements.
Mitchell
News Release
Missouri, Washington and West Virginia Adopt Emergency Changes
Mitchell Pharmacy Solutions is actively monitoring the evolving landscape related to the COVID-19 pandemic.
Workers' Comp
Article
Continuing Care During COVID-19
“Genex Works: Moving claims forward during COVID-19,” is a regular series designed to provide you with updates on how Genex is working with c
Mitchell
News Release
Mitchell Intelligent Estimating Solution Ready for U.S. Early Adopters
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Workers' Comp
Blog
As robots come to work, our tasks will include safety and quality
Robots are coming for your job. That’s the thrust of much of the discussion around automation and work.
Workers' Comp
Article
Moving claims forward during COVID-19 - Guidelines
In the face of a crisis, the workers’ comp community has historically pulled together to overcome whatever obstacle that’s come our way.